Excess fat in morbidly obese patients undergoing unique effective treatment such as bariatric surgery, is accumulated not only in adipose tissue but also in other tissues and organs. In the liver, this process leads to fatty liver disease, which has a complicated course [1, 2] . The disease progresses from simple steatosis, through inflammation to fibrosis, cirrhosis and liver failure. It should be noted that according to the World Gastroenterological Organization non-alcoholic fatty liver disease (NAFLD) affected 20-40% of general population and as much as 75-95% of people with pathological obesity. Inflammatory form of the disease was present in 10-20% of the general population and in even 37% of obese patients [3] .
The only method to diagnose the disease is biopsy, but it is not widely used due to potential complications. Non-invasive imaging modalities (ultrasonography, computed tomography, magnetic resonance imaging) are also available, but have many limitations.
Many authors indicate also the possibility of using composite biomarkers in the diagnosis of NAFLD in the aim to find the simplest marker possible for use in everyday clinical practice [4] [5] [6] . In some studies, high sensivity C-reactive protein (hsCRP) was reported to be an independent risk factor for NAFLD [7] [8] [9] .
Since non-invasive methods have limited application in the diagnosis of the disease and assessment of its course, it is virtually impossible to safely monitor the potential evolution of changes in liver after surgical treatment. The objective of the study was to find a noninvasive predictor of liver disorders in patients after bariatric surgeries and to assess the prevalence of NAFLD and the impact of bariatric surgeries on the histopathology of the liver. ordinal variables were tested using contingency tables and chi-square independence tests. To assess the difference in the probability of the occurrence of phenomenon (increased hsCRP) between two groups, the odds ratio with 95% confidence interval and the significance test was used. The analysis of ROC curves was used to evaluate the diagnostic power of the test.
Significance level below which results were considered significant was P<0.05. The calculations were performed in IBM SPSS 23.0 and MedCalc. The study protocol was accepted by Medical University of Warsaw.
The study group included 24 patients, all were diagnosed with grade 3 obesity ( Table   1 ). The effectiveness of surgical treatment was assessed on the basis of anthropometric analysis performed at the beginning of the therapy "0", 12 months after the surgery "12" and one day before the abdominal wall plasty "E". The treatment was considered effective if EWL was at least 50% and EBMIL was 60%.
Analysis of anthropometric parameters in the study group revealed statistically significant differences (Table 1) . One year after surgery, a positive therapeutic effect, that is at least minimal required percentage of EWL and percentage of EBMIL, was observed in 62.5% and 87.5% of patients, respectively. At the end of the study, regardless of the criterion used, the whole group achieved positive therapeutic effect. The results of surgical treatment were also evaluated in terms of the histopathology of the liver. There were only small differences identified in %EWL and %EBMIL between patients with different severity of steatosis. These differences, however, were not statistically significant. 
